Molecular basis of human CD22 function and therapeutic targeting
The B-cell-specific co-receptor CD22 is a therapeutic target for depleting dysregulated B cells. Here the authors structurally characterize the ectodomain of CD22 and present its crystal structure with the bound therapeutic antibody epratuzumab, which gives insights into the mechanism of inhibition...
Guardado en:
Autores principales: | June Ereño-Orbea, Taylor Sicard, Hong Cui, Mohammad T. Mazhab-Jafari, Samir Benlekbir, Alba Guarné, John L. Rubinstein, Jean-Philippe Julien |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04e84326931749769862d90cdc858a46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular Recognition Insights of Sialic Acid Glycans by Distinct Receptors Unveiled by NMR and Molecular Modeling
por: Cátia Oliveira Soares, et al.
Publicado: (2021) -
Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
por: Edurne Rujas, et al.
Publicado: (2020) -
Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28−, Th22 and Tfh and B lymphocytes
por: Alba Mangas-Losada, et al.
Publicado: (2017) -
Structural basis of substrate recognition and thermal protection by a small heat shock protein
por: Chuanyang Yu, et al.
Publicado: (2021) -
The structural basis for CD36 binding by the malaria parasite
por: Fu-Lien Hsieh, et al.
Publicado: (2016)